Atlas Trials

Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT00017251 · COMPLETED

Trial details

NCT number
NCT00017251
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Extensive Stage Small Cell Lung Cancer
Start date
2001-04-01
Primary completion
2004-01-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.